Health care stocks edged higher Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each increasing 0.1%.
The iShares Biotechnology ETF (IBB) eased 0.2%.
In corporate news, Eli Lilly (LLY) shares rose 2.8% after the company said it will increase the UK price of its weight-loss and type 2 diabetes drug Mounjaro starting in September for alignment with other developed countries.
Trinity Biotech (TRIB) shares surged 83% after the company said it received approval from the New York State Department of Health to start providing its PreClara Ratio biomarker test for the assessment of preeclampsia risk.
Philips (PHG) shares were down 0.6% after it said Thursday it plans to invest over $150 million in US manufacturing and research and development.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.